Modifications

* The in vitro [[GcMAF]] effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages. [[Dario Siniscalco|Siniscalco D]], [[Jeff Bradstreet|Bradstreet JJ]], Cirillo A, Antonucci N. J Neuroinflammation. 2014 Apr 17

* The in vitro [[GcMAF]] effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages. [[Dario Siniscalco|Siniscalco D]], [[Jeff Bradstreet|Bradstreet JJ]], Cirillo A, Antonucci N. J Neuroinflammation. 2014 Apr 17

* Possible use of Trichuris suis ova in autism spectrum disorders therapy. [[Dario Siniscalco|Siniscalco D]], Antonucci N. [[Medical Hypotheses|Med Hypotheses]]. 2013 Jul

* Possible use of Trichuris suis ova in autism spectrum disorders therapy. [[Dario Siniscalco|Siniscalco D]], Antonucci N. [[Medical Hypotheses|Med Hypotheses]]. 2013 Jul

* Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders. [[Dario Siniscalco|Siniscalco D]], Sapone A, Giordano C, Cirillo A, de Magistris L, Rossi F, Fasano A, [[Jeff Bradstreet|Bradstreet JJ]], Maione S, Antonucci N. Autism Dev Disord. 2013 Nov

* Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders. [[Dario Siniscalco|Siniscalco D]], Sapone A, Giordano C, Cirillo A, de Magistris L, Rossi F, [[Alessio Fasano|Fasano A]], [[Jeff Bradstreet|Bradstreet JJ]], Maione S, Antonucci N. Autism Dev Disord. 2013 Nov

* The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients. [[Dario Siniscalco|Siniscalco D]], Sapone A, Giordano C, Cirillo A, de Novellis V, de Magistris L, Rossi F, [[Alessio Fasano| Fasano A]], Maione S, Antonucci N. J Autism Dev Disord. 2012 <ref>http://www.emergenzautismo.org/images/_sezioni/biomedico/siniscalco.pdf Accès à l'article complet "The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients."</ref>

* The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients. [[Dario Siniscalco|Siniscalco D]], Sapone A, Giordano C, Cirillo A, de Novellis V, de Magistris L, Rossi F, [[Alessio Fasano|Fasano A]], Maione S, Antonucci N. J Autism Dev Disord. 2012 <ref>http://www.emergenzautismo.org/images/_sezioni/biomedico/siniscalco.pdf Accès à l'article complet "The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients."</ref>

* Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future? [[Dario Siniscalco|Siniscalco D]], Sapone A, Cirillo A, Giordano C, Maione S, Antonucci N. J Biomed Biotechnol. 2012

* Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future? [[Dario Siniscalco|Siniscalco D]], Sapone A, Cirillo A, Giordano C, Maione S, Antonucci N. J Biomed Biotechnol. 2012